Coherus Oncology, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Coherus Oncology, Inc. (CHRS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$8.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-05
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$1.28M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$7.16M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $4.44M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.27M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$9.20M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$56.88M.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.20M, a 93.34% decline from fiscal 2021.
- Coherus Oncology, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $17.93M, a 258.93% increase from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$8.45M 10-Q · filed 2026-08-05 | -$4.01M derived: sum of 3 quarters · filed 2026-08-05 | -$2.73M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$7.16M 10-Q · filed 2026-05-11 | -$2.73M derived: sum of 2 quarters · filed 2026-05-11 | -$1.45M derived: sum of 3 quarters · filed 2026-05-11 | -$8.04M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $5.71M derived: sum of 2 quarters · filed 2026-03-09 | -$874.00K derived: sum of 3 quarters · filed 2026-08-05 | -$9.20M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.31M derived: sum of 2 quarters · filed 2026-08-05 | -$13.64M 10-Q · filed 2025-11-06 | -$19.61M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$6.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$14.91M 10-Q · filed 2026-08-05 | -$20.88M derived: sum of 3 quarters · filed 2026-08-05 | -$25.92M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$8.32M 10-Q · filed 2026-05-11 | -$14.30M derived: sum of 2 quarters · filed 2026-05-11 | -$19.33M derived: sum of 3 quarters · filed 2026-05-11 | -$65.94M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$11.01M derived: sum of 2 quarters · filed 2026-03-09 | -$57.62M derived: sum of 3 quarters · filed 2026-03-09 | -$56.88M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$51.65M derived: sum of 2 quarters · filed 2025-11-06 | -$50.91M 10-Q · filed 2025-11-06 | -$47.21M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$46.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$45.87M 10-Q · filed 2025-08-07 | -$42.18M derived: sum of 3 quarters · filed 2025-11-13 | -$25.66M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-03-31 | $741.00K 10-Q · filed 2025-05-12 | $4.43M derived: sum of 2 quarters · filed 2025-11-13 | $20.95M derived: sum of 3 quarters · filed 2025-11-13 | $33.57M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2023-12-31 | $3.69M derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | $20.21M derived: sum of 2 quarters · filed 2025-11-13 | $32.83M derived: sum of 3 quarters · filed 2025-11-13 | $10.92M 8-K · filed 2025-11-13 | ||||
| 2023-09-30 | $16.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $29.13M derived: sum of 2 quarters · filed 2024-11-06 | $7.22M 10-Q · filed 2024-11-06 | -$23.90M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $12.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$9.29M 10-Q · filed 2024-08-08 | -$40.42M derived: sum of 3 quarters · filed 2025-03-17 | $487.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$21.91M 10-Q · filed 2024-05-09 | -$53.03M derived: sum of 2 quarters · filed 2025-03-17 | -$12.13M derived: sum of 3 quarters · filed 2025-03-17 | -$17.47M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$31.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $9.78M derived: sum of 2 quarters · filed 2025-03-17 | $4.44M derived: sum of 3 quarters · filed 2025-03-17 | $1.20M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $40.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $35.56M derived: sum of 2 quarters · filed 2023-11-06 | $32.32M 10-Q · filed 2023-11-06 | $33.72M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$8.59M 10-Q · filed 2023-08-02 | -$7.18M derived: sum of 3 quarters · filed 2024-03-15 | -$17.11M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$3.24M 10-Q · filed 2023-05-08 | -$1.84M derived: sum of 2 quarters · filed 2024-03-15 | -$11.77M derived: sum of 3 quarters · filed 2024-03-15 | -$2.21M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$8.53M derived: sum of 2 quarters · filed 2024-03-15 | $1.03M derived: sum of 3 quarters · filed 2024-03-15 | $17.93M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | -$9.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$371.00K derived: sum of 2 quarters · filed 2022-11-08 | $16.53M 10-Q · filed 2022-11-08 | $15.29M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $26.46M 10-Q · filed 2022-08-04 | $25.23M derived: sum of 3 quarters · filed 2023-03-06 | $24.02M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $16.90M 10-Q · filed 2022-05-05 | $15.66M derived: sum of 2 quarters · filed 2023-03-06 | $14.45M derived: sum of 3 quarters · filed 2023-03-06 | $20.25M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$2.44M derived: sum of 2 quarters · filed 2023-03-06 | $3.35M derived: sum of 3 quarters · filed 2023-03-06 | $5.00M 10-K · filed 2023-03-06 | $5.49M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $4.59M derived: sum of 2 quarters · filed 2021-11-08 | $6.23M 10-Q · filed 2021-11-08 | $5.52M 10-Q · filed 2020-11-05 | $5.16M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-06-30 | $5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $7.44M 10-Q · filed 2021-08-05 | $7.76M 10-Q · filed 2020-08-06 | $6.37M derived: sum of 3 quarters · filed 2022-02-23 | $14.47M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-03-31 | $1.65M 10-Q · filed 2021-05-06 | $2.13M 10-Q · filed 2020-05-07 | $576.00K derived: sum of 2 quarters · filed 2022-02-23 | $8.68M derived: sum of 3 quarters · filed 2022-02-23 | $7.96M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $7.03M derived: sum of 2 quarters · filed 2022-02-23 | $6.32M derived: sum of 3 quarters · filed 2022-02-23 | $8.35M 10-K · filed 2022-02-23 | $10.39M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.39M derived: sum of 2 quarters · filed 2020-11-05 | $9.42M 10-Q · filed 2020-11-05 | $7.70M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.32M 10-Q · filed 2020-08-06 | -$400.00K derived: sum of 3 quarters · filed 2021-02-25 | $5.08M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.03M 10-Q · filed 2020-05-07 | $310.00K derived: sum of 2 quarters · filed 2021-02-25 | $5.79M derived: sum of 3 quarters · filed 2021-02-25 | $3.59M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.77M derived: sum of 2 quarters · filed 2021-02-25 | $1.57M derived: sum of 3 quarters · filed 2021-02-25 | $69.00K 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.28M derived: sum of 2 quarters · filed 2019-11-08 | $1.79M 10-Q · filed 2019-11-08 | $7.61M 10-Q · filed 2018-11-08 | -$2.42M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$3.70M 10-Q · filed 2019-08-05 | -$586.00K 10-Q · filed 2018-08-08 | -$7.90M derived: sum of 3 quarters · filed 2020-02-27 | -$6.67M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-03-31 | -$1.50M 10-Q · filed 2019-05-09 | $456.00K 10-Q · filed 2018-05-10 | -$5.70M derived: sum of 2 quarters · filed 2020-02-27 | -$4.47M derived: sum of 3 quarters · filed 2020-02-27 | -$10.74M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2017-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$2.98M derived: sum of 2 quarters · filed 2020-02-27 | -$9.25M derived: sum of 3 quarters · filed 2020-02-27 | -$14.08M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$5.04M derived: sum of 2 quarters · filed 2018-11-08 | -$9.87M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$11.10M 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | -$4.83M 10-Q · filed 2018-05-10 | |||||||
| 2016-09-30 | $4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $4.66M derived: sum of 2 quarters · filed 2017-11-06 | -$75.00K 10-Q · filed 2017-11-06 | |||||
| 2016-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$4.85M 10-Q · filed 2017-08-07 | ||||||
| 2016-03-31 | -$4.74M 10-Q · filed 2017-05-08 | |||||||
| 2015-09-30 | $6.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $11.83M derived: sum of 2 quarters · filed 2016-11-09 | $13.77M 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $7.51M 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $1.94M 10-Q · filed 2016-05-09 | |||||||
| 2014-09-30 | $797.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $2.99M derived: sum of 2 quarters · filed 2015-11-10 | $498.00K 10-Q · filed 2015-11-10 | |||||
| 2014-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$299.00K 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$2.49M 10-Q · filed 2015-05-11 | |||||||
| 2013-09-30 | $735.00K 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |